The potential of patient-derived organoids in precision medicine of biliary tract cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37992681.
- Also identified by DOI 10.1016/j.xcrm.2023.101294 and PMC identifier 10694744.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemotherapy resistance in biliary tract cancer (BTC) presents a major clinical hurdle. Ren et al.<sup>1</sup> developed and characterized an extensive collection of BTC patient-derived organoid (PDO) models, enabling advanced investigation of chemotherapy response prediction.
Medical subject headings
- Precision Medicine
- Biliary Tract Neoplasms